Literature DB >> 1784242

Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compounds.

M R Franklin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1784242     DOI: 10.1016/0076-6879(91)06126-n

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  10 in total

1.  Effects of the administration of spiramycin and tiamulin on in vivo complex formation and hepatic cytochrome P4503A (CYP3A)-dependent monooxygenases in rabbits.

Authors:  M Cantiello; A Zaghini; C Nebbia; M Carletti; M Dacasto; P Anfossi
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate.

Authors:  Thomas M Polasek; John O Miners
Journal:  Eur J Clin Pharmacol       Date:  2006-01-17       Impact factor: 2.953

3.  Cytochrome P-450 complex formation in rat liver by the antibiotic tiamulin.

Authors:  R F Witkamp; S M Nijmeijer; A S van Miert
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Piperonylic acid, a selective, mechanism-based inactivator of the trans-cinnamate 4-hydroxylase: A new tool to control the flux of metabolites in the phenylpropanoid pathway

Authors: 
Journal:  Plant Physiol       Date:  1998-09       Impact factor: 8.340

5.  In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A.

Authors:  Thomas M Polasek; Janani S Sadagopal; David J Elliot; John O Miners
Journal:  Eur J Clin Pharmacol       Date:  2009-12-11       Impact factor: 2.953

Review 6.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

7.  Upregulation of cytochromes P450 2B in rat liver by orphenadrine.

Authors:  Michael Murray; Eva Fiala-Beer; Dylan Sutton
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

Review 8.  Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

Authors:  Shufeng Zhou; Sui Yung Chan; Boon Cher Goh; Eli Chan; Wei Duan; Min Huang; Howard L McLeod
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

9.  Time-dependent inhibition of CYP3A4-mediated midazolam metabolism by macrolide antibiotics in CYP3A4 genetic variants: Comparison with testosterone metabolism.

Authors:  Takeshi Akiyoshi; Rina Naitou; Ayuko Imaoka; Mitsue Miyazaki; F Peter Guengerich; Katsunori Nakamura; Koujiro Yamamoto; Hisakazu Ohtani
Journal:  Int J Clin Pharmacol Ther       Date:  2021-12       Impact factor: 1.366

10.  Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.

Authors:  Shufeng Zhou; Eli Chan; Xiaotian Li; Min Huang
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.